Menu
Search
|

Menu

Close
X

Zhejiang Ausun Pharmaceutical Co Ltd 603229.SS (Shanghai Stock Exchange)

13.48 CNY
-0.27 (-1.96%)
As of 8:00 AM BST
Previous Close 13.75
Open 13.65
Volume 873,951
3m Avg Volume 1,292,044
Today’s High 13.78
Today’s Low 13.06
52 Week High 17.37
52 Week Low 10.15
Shares Outstanding (mil) 160.00
Market Capitalization (mil) 3,064.00
Forward P/E 38.50
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, CNY)
FY19
58
FY18
244
FY17
240
FY16
199
EPS (CNY)
FY19
0.049
FY18
0.274
FY17
0.376
FY16
0.481
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
38.50
32.67
Price to Sales (TTM)
vs sector
14.18
7.92
Price to Book (MRQ)
vs sector
5.71
5.39
Price to Cash Flow (TTM)
vs sector
67.99
24.37
Total Debt to Equity (MRQ)
vs sector
12.48
14.57
LT Debt to Equity (MRQ)
vs sector
0.00
10.21
Return on Investment (TTM)
vs sector
--
14.49
Return on Equity (TTM)
vs sector
--
15.79

EXECUTIVE LEADERSHIP

Zhiguo Zheng
Chairman of the Board, General Manager, Since
Salary: --
Bonus: --
Hang Lou
Finance Director, Deputy General Manager, Secretary of the Board, Since
Salary: --
Bonus: --
Huadong Zhang
Deputy General Manager, Director, Since
Salary: --
Bonus: --
Ribao Zhou
Deputy General Manager, Director, Since
Salary: --
Bonus: --
Fei Chen
Director, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

TAIZHOU   ZHJ   317016

Phone: +86576.85589367

Zhejiang Ausun Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of specialty bulk pharmaceutical chemicals (BPCs) and pharmaceutical intermediates. The Company's main products include bimatoprost, latanoprost, latanoprostene bunod, entecavir, selectfluor and other intermediates. The Company is also involved in the provision of customized production, as well as research and development services to customers through its subsidiaries.

SPONSORED STORIES